nodes	percent_of_prediction	percent_of_DWPC	metapath
Valsartan—SLCO1B3—Paclitaxel—ovarian cancer	0.355	0.528	CbGbCtD
Valsartan—SLCO1B3—Docetaxel—ovarian cancer	0.256	0.382	CbGbCtD
Valsartan—CYP2C9—Paclitaxel—ovarian cancer	0.0609	0.0907	CbGbCtD
Valsartan—Mediastinal disorder—Docetaxel—ovarian cancer	0.000526	0.0016	CcSEcCtD
Valsartan—Rash—Melphalan—ovarian cancer	0.000525	0.0016	CcSEcCtD
Valsartan—Dermatitis—Melphalan—ovarian cancer	0.000525	0.0016	CcSEcCtD
Valsartan—Cough—Paclitaxel—ovarian cancer	0.000523	0.00159	CcSEcCtD
Valsartan—Asthenia—Vinorelbine—ovarian cancer	0.000522	0.00159	CcSEcCtD
Valsartan—Orthostatic hypotension—Epirubicin—ovarian cancer	0.00052	0.00158	CcSEcCtD
Valsartan—Abdominal pain upper—Epirubicin—ovarian cancer	0.00052	0.00158	CcSEcCtD
Valsartan—Alopecia—Docetaxel—ovarian cancer	0.000516	0.00157	CcSEcCtD
Valsartan—Pruritus—Vinorelbine—ovarian cancer	0.000515	0.00157	CcSEcCtD
Valsartan—Mental disorder—Docetaxel—ovarian cancer	0.000512	0.00156	CcSEcCtD
Valsartan—Myalgia—Paclitaxel—ovarian cancer	0.000511	0.00156	CcSEcCtD
Valsartan—Chest pain—Paclitaxel—ovarian cancer	0.000511	0.00156	CcSEcCtD
Valsartan—Arthralgia—Paclitaxel—ovarian cancer	0.000511	0.00156	CcSEcCtD
Valsartan—Anxiety—Paclitaxel—ovarian cancer	0.000509	0.00155	CcSEcCtD
Valsartan—Malnutrition—Docetaxel—ovarian cancer	0.000508	0.00155	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000507	0.00154	CcSEcCtD
Valsartan—Nausea—Topotecan—ovarian cancer	0.000505	0.00154	CcSEcCtD
Valsartan—Muscular weakness—Epirubicin—ovarian cancer	0.000502	0.00153	CcSEcCtD
Valsartan—Dry mouth—Paclitaxel—ovarian cancer	0.000499	0.00152	CcSEcCtD
Valsartan—Diarrhoea—Vinorelbine—ovarian cancer	0.000498	0.00152	CcSEcCtD
Valsartan—Dysgeusia—Docetaxel—ovarian cancer	0.000498	0.00152	CcSEcCtD
Valsartan—Nausea—Melphalan—ovarian cancer	0.000495	0.00151	CcSEcCtD
Valsartan—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000494	0.0015	CcSEcCtD
Valsartan—Back pain—Docetaxel—ovarian cancer	0.000492	0.0015	CcSEcCtD
Valsartan—Oedema—Paclitaxel—ovarian cancer	0.000489	0.00149	CcSEcCtD
Valsartan—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000489	0.00149	CcSEcCtD
Valsartan—Muscle spasms—Docetaxel—ovarian cancer	0.000489	0.00149	CcSEcCtD
Valsartan—Infection—Paclitaxel—ovarian cancer	0.000486	0.00148	CcSEcCtD
Valsartan—Shock—Paclitaxel—ovarian cancer	0.000482	0.00147	CcSEcCtD
Valsartan—Dizziness—Vinorelbine—ovarian cancer	0.000481	0.00147	CcSEcCtD
Valsartan—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000481	0.00147	CcSEcCtD
Valsartan—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000481	0.00147	CcSEcCtD
Valsartan—Nervous system disorder—Paclitaxel—ovarian cancer	0.00048	0.00146	CcSEcCtD
Valsartan—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000479	0.00146	CcSEcCtD
Valsartan—Skin disorder—Paclitaxel—ovarian cancer	0.000475	0.00145	CcSEcCtD
Valsartan—Bronchitis—Epirubicin—ovarian cancer	0.000473	0.00144	CcSEcCtD
Valsartan—Anorexia—Paclitaxel—ovarian cancer	0.000467	0.00142	CcSEcCtD
Valsartan—Muscular weakness—Doxorubicin—ovarian cancer	0.000465	0.00142	CcSEcCtD
Valsartan—Vomiting—Vinorelbine—ovarian cancer	0.000463	0.00141	CcSEcCtD
Valsartan—Neutropenia—Epirubicin—ovarian cancer	0.00046	0.0014	CcSEcCtD
Valsartan—Rash—Vinorelbine—ovarian cancer	0.000459	0.0014	CcSEcCtD
Valsartan—Dermatitis—Vinorelbine—ovarian cancer	0.000458	0.0014	CcSEcCtD
Valsartan—Hypotension—Paclitaxel—ovarian cancer	0.000457	0.00139	CcSEcCtD
Valsartan—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000457	0.00139	CcSEcCtD
Valsartan—Headache—Vinorelbine—ovarian cancer	0.000456	0.00139	CcSEcCtD
Valsartan—Syncope—Docetaxel—ovarian cancer	0.000456	0.00139	CcSEcCtD
Valsartan—Palpitations—Docetaxel—ovarian cancer	0.000449	0.00137	CcSEcCtD
Valsartan—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000449	0.00137	CcSEcCtD
Valsartan—Loss of consciousness—Docetaxel—ovarian cancer	0.000447	0.00136	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000446	0.00136	CcSEcCtD
Valsartan—Cough—Docetaxel—ovarian cancer	0.000444	0.00135	CcSEcCtD
Valsartan—Insomnia—Paclitaxel—ovarian cancer	0.000443	0.00135	CcSEcCtD
Valsartan—Paraesthesia—Paclitaxel—ovarian cancer	0.00044	0.00134	CcSEcCtD
Valsartan—Infestation NOS—Epirubicin—ovarian cancer	0.000439	0.00134	CcSEcCtD
Valsartan—Infestation—Epirubicin—ovarian cancer	0.000439	0.00134	CcSEcCtD
Valsartan—Bronchitis—Doxorubicin—ovarian cancer	0.000438	0.00133	CcSEcCtD
Valsartan—Dyspnoea—Paclitaxel—ovarian cancer	0.000436	0.00133	CcSEcCtD
Valsartan—Somnolence—Paclitaxel—ovarian cancer	0.000435	0.00133	CcSEcCtD
Valsartan—Myalgia—Docetaxel—ovarian cancer	0.000433	0.00132	CcSEcCtD
Valsartan—Arthralgia—Docetaxel—ovarian cancer	0.000433	0.00132	CcSEcCtD
Valsartan—Chest pain—Docetaxel—ovarian cancer	0.000433	0.00132	CcSEcCtD
Valsartan—Nausea—Vinorelbine—ovarian cancer	0.000432	0.00132	CcSEcCtD
Valsartan—Renal failure—Epirubicin—ovarian cancer	0.000431	0.00131	CcSEcCtD
Valsartan—Dyspepsia—Paclitaxel—ovarian cancer	0.000431	0.00131	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00043	0.00131	CcSEcCtD
Valsartan—Neutropenia—Doxorubicin—ovarian cancer	0.000426	0.0013	CcSEcCtD
Valsartan—Decreased appetite—Paclitaxel—ovarian cancer	0.000425	0.0013	CcSEcCtD
Valsartan—Dry mouth—Docetaxel—ovarian cancer	0.000423	0.00129	CcSEcCtD
Valsartan—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000423	0.00129	CcSEcCtD
Valsartan—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000423	0.00129	CcSEcCtD
Valsartan—Fatigue—Paclitaxel—ovarian cancer	0.000422	0.00129	CcSEcCtD
Valsartan—Constipation—Paclitaxel—ovarian cancer	0.000419	0.00128	CcSEcCtD
Valsartan—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000416	0.00127	CcSEcCtD
Valsartan—Anaphylactic shock—Docetaxel—ovarian cancer	0.000415	0.00126	CcSEcCtD
Valsartan—Oedema—Docetaxel—ovarian cancer	0.000415	0.00126	CcSEcCtD
Valsartan—Epistaxis—Epirubicin—ovarian cancer	0.000414	0.00126	CcSEcCtD
Valsartan—Infection—Docetaxel—ovarian cancer	0.000412	0.00126	CcSEcCtD
Valsartan—Sinusitis—Epirubicin—ovarian cancer	0.000412	0.00125	CcSEcCtD
Valsartan—Shock—Docetaxel—ovarian cancer	0.000408	0.00124	CcSEcCtD
Valsartan—Nervous system disorder—Docetaxel—ovarian cancer	0.000407	0.00124	CcSEcCtD
Valsartan—Thrombocytopenia—Docetaxel—ovarian cancer	0.000406	0.00124	CcSEcCtD
Valsartan—Infestation NOS—Doxorubicin—ovarian cancer	0.000406	0.00124	CcSEcCtD
Valsartan—Infestation—Doxorubicin—ovarian cancer	0.000406	0.00124	CcSEcCtD
Valsartan—Skin disorder—Docetaxel—ovarian cancer	0.000403	0.00123	CcSEcCtD
Valsartan—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.0004	0.00122	CcSEcCtD
Valsartan—Renal failure—Doxorubicin—ovarian cancer	0.000399	0.00122	CcSEcCtD
Valsartan—Haemoglobin—Epirubicin—ovarian cancer	0.000396	0.00121	CcSEcCtD
Valsartan—Anorexia—Docetaxel—ovarian cancer	0.000395	0.0012	CcSEcCtD
Valsartan—Rhinitis—Epirubicin—ovarian cancer	0.000395	0.0012	CcSEcCtD
Valsartan—Hepatitis—Epirubicin—ovarian cancer	0.000394	0.0012	CcSEcCtD
Valsartan—Haemorrhage—Epirubicin—ovarian cancer	0.000394	0.0012	CcSEcCtD
Valsartan—Pharyngitis—Epirubicin—ovarian cancer	0.000391	0.00119	CcSEcCtD
Valsartan—Urinary tract disorder—Epirubicin—ovarian cancer	0.000389	0.00118	CcSEcCtD
Valsartan—Urticaria—Paclitaxel—ovarian cancer	0.000389	0.00118	CcSEcCtD
Valsartan—Hypotension—Docetaxel—ovarian cancer	0.000388	0.00118	CcSEcCtD
Valsartan—Connective tissue disorder—Epirubicin—ovarian cancer	0.000387	0.00118	CcSEcCtD
Valsartan—Abdominal pain—Paclitaxel—ovarian cancer	0.000387	0.00118	CcSEcCtD
Valsartan—Urethral disorder—Epirubicin—ovarian cancer	0.000386	0.00118	CcSEcCtD
Valsartan—Epistaxis—Doxorubicin—ovarian cancer	0.000383	0.00117	CcSEcCtD
Valsartan—Sinusitis—Doxorubicin—ovarian cancer	0.000381	0.00116	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000378	0.00115	CcSEcCtD
Valsartan—Insomnia—Docetaxel—ovarian cancer	0.000375	0.00114	CcSEcCtD
Valsartan—Paraesthesia—Docetaxel—ovarian cancer	0.000373	0.00113	CcSEcCtD
Valsartan—Dyspnoea—Docetaxel—ovarian cancer	0.00037	0.00113	CcSEcCtD
Valsartan—Somnolence—Docetaxel—ovarian cancer	0.000369	0.00112	CcSEcCtD
Valsartan—Haemoglobin—Doxorubicin—ovarian cancer	0.000366	0.00112	CcSEcCtD
Valsartan—Cardiac disorder—Epirubicin—ovarian cancer	0.000366	0.00111	CcSEcCtD
Valsartan—Rhinitis—Doxorubicin—ovarian cancer	0.000365	0.00111	CcSEcCtD
Valsartan—Dyspepsia—Docetaxel—ovarian cancer	0.000365	0.00111	CcSEcCtD
Valsartan—Haemorrhage—Doxorubicin—ovarian cancer	0.000364	0.00111	CcSEcCtD
Valsartan—Hepatitis—Doxorubicin—ovarian cancer	0.000364	0.00111	CcSEcCtD
Valsartan—Pharyngitis—Doxorubicin—ovarian cancer	0.000362	0.0011	CcSEcCtD
Valsartan—Decreased appetite—Docetaxel—ovarian cancer	0.000361	0.0011	CcSEcCtD
Valsartan—Hypersensitivity—Paclitaxel—ovarian cancer	0.000361	0.0011	CcSEcCtD
Valsartan—Urinary tract disorder—Doxorubicin—ovarian cancer	0.00036	0.0011	CcSEcCtD
Valsartan—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000358	0.00109	CcSEcCtD
Valsartan—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000358	0.00109	CcSEcCtD
Valsartan—Fatigue—Docetaxel—ovarian cancer	0.000358	0.00109	CcSEcCtD
Valsartan—Angiopathy—Epirubicin—ovarian cancer	0.000357	0.00109	CcSEcCtD
Valsartan—Urethral disorder—Doxorubicin—ovarian cancer	0.000357	0.00109	CcSEcCtD
Valsartan—Immune system disorder—Epirubicin—ovarian cancer	0.000356	0.00108	CcSEcCtD
Valsartan—Mediastinal disorder—Epirubicin—ovarian cancer	0.000355	0.00108	CcSEcCtD
Valsartan—Constipation—Docetaxel—ovarian cancer	0.000355	0.00108	CcSEcCtD
Valsartan—Asthenia—Paclitaxel—ovarian cancer	0.000351	0.00107	CcSEcCtD
Valsartan—Alopecia—Epirubicin—ovarian cancer	0.000348	0.00106	CcSEcCtD
Valsartan—Pruritus—Paclitaxel—ovarian cancer	0.000346	0.00105	CcSEcCtD
Valsartan—Mental disorder—Epirubicin—ovarian cancer	0.000345	0.00105	CcSEcCtD
Valsartan—Malnutrition—Epirubicin—ovarian cancer	0.000343	0.00104	CcSEcCtD
Valsartan—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000339	0.00103	CcSEcCtD
Valsartan—Cardiac disorder—Doxorubicin—ovarian cancer	0.000338	0.00103	CcSEcCtD
Valsartan—Flatulence—Epirubicin—ovarian cancer	0.000338	0.00103	CcSEcCtD
Valsartan—Dysgeusia—Epirubicin—ovarian cancer	0.000336	0.00102	CcSEcCtD
Valsartan—Diarrhoea—Paclitaxel—ovarian cancer	0.000335	0.00102	CcSEcCtD
Valsartan—Back pain—Epirubicin—ovarian cancer	0.000332	0.00101	CcSEcCtD
Valsartan—Angiopathy—Doxorubicin—ovarian cancer	0.000331	0.00101	CcSEcCtD
Valsartan—Muscle spasms—Epirubicin—ovarian cancer	0.00033	0.001	CcSEcCtD
Valsartan—Immune system disorder—Doxorubicin—ovarian cancer	0.000329	0.001	CcSEcCtD
Valsartan—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000328	0.001	CcSEcCtD
Valsartan—Abdominal pain—Docetaxel—ovarian cancer	0.000328	0.000999	CcSEcCtD
Valsartan—Dizziness—Paclitaxel—ovarian cancer	0.000324	0.000986	CcSEcCtD
Valsartan—Vision blurred—Epirubicin—ovarian cancer	0.000323	0.000984	CcSEcCtD
Valsartan—Alopecia—Doxorubicin—ovarian cancer	0.000322	0.000981	CcSEcCtD
Valsartan—Mental disorder—Doxorubicin—ovarian cancer	0.000319	0.000973	CcSEcCtD
Valsartan—Malnutrition—Doxorubicin—ovarian cancer	0.000317	0.000966	CcSEcCtD
Valsartan—Flatulence—Doxorubicin—ovarian cancer	0.000313	0.000952	CcSEcCtD
Valsartan—Vomiting—Paclitaxel—ovarian cancer	0.000311	0.000948	CcSEcCtD
Valsartan—Dysgeusia—Doxorubicin—ovarian cancer	0.000311	0.000946	CcSEcCtD
Valsartan—Rash—Paclitaxel—ovarian cancer	0.000309	0.00094	CcSEcCtD
Valsartan—Dermatitis—Paclitaxel—ovarian cancer	0.000308	0.000939	CcSEcCtD
Valsartan—Vertigo—Epirubicin—ovarian cancer	0.000308	0.000938	CcSEcCtD
Valsartan—Syncope—Epirubicin—ovarian cancer	0.000307	0.000937	CcSEcCtD
Valsartan—Back pain—Doxorubicin—ovarian cancer	0.000307	0.000935	CcSEcCtD
Valsartan—Headache—Paclitaxel—ovarian cancer	0.000307	0.000934	CcSEcCtD
Valsartan—Hypersensitivity—Docetaxel—ovarian cancer	0.000306	0.000931	CcSEcCtD
Valsartan—Muscle spasms—Doxorubicin—ovarian cancer	0.000305	0.000929	CcSEcCtD
Valsartan—Palpitations—Epirubicin—ovarian cancer	0.000303	0.000923	CcSEcCtD
Valsartan—Loss of consciousness—Epirubicin—ovarian cancer	0.000301	0.000918	CcSEcCtD
Valsartan—Cough—Epirubicin—ovarian cancer	0.000299	0.000911	CcSEcCtD
Valsartan—Vision blurred—Doxorubicin—ovarian cancer	0.000299	0.000911	CcSEcCtD
Valsartan—Asthenia—Docetaxel—ovarian cancer	0.000298	0.000907	CcSEcCtD
Valsartan—Pruritus—Docetaxel—ovarian cancer	0.000294	0.000894	CcSEcCtD
Valsartan—Myalgia—Epirubicin—ovarian cancer	0.000292	0.000889	CcSEcCtD
Valsartan—Arthralgia—Epirubicin—ovarian cancer	0.000292	0.000889	CcSEcCtD
Valsartan—Chest pain—Epirubicin—ovarian cancer	0.000292	0.000889	CcSEcCtD
Valsartan—Anxiety—Epirubicin—ovarian cancer	0.000291	0.000886	CcSEcCtD
Valsartan—Nausea—Paclitaxel—ovarian cancer	0.000291	0.000886	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.00029	0.000883	CcSEcCtD
Valsartan—Dry mouth—Epirubicin—ovarian cancer	0.000285	0.00087	CcSEcCtD
Valsartan—Vertigo—Doxorubicin—ovarian cancer	0.000285	0.000868	CcSEcCtD
Valsartan—Syncope—Doxorubicin—ovarian cancer	0.000284	0.000867	CcSEcCtD
Valsartan—Diarrhoea—Docetaxel—ovarian cancer	0.000284	0.000865	CcSEcCtD
Valsartan—Palpitations—Doxorubicin—ovarian cancer	0.00028	0.000854	CcSEcCtD
Valsartan—Oedema—Epirubicin—ovarian cancer	0.00028	0.000852	CcSEcCtD
Valsartan—Anaphylactic shock—Epirubicin—ovarian cancer	0.00028	0.000852	CcSEcCtD
Valsartan—Loss of consciousness—Doxorubicin—ovarian cancer	0.000279	0.000849	CcSEcCtD
Valsartan—Infection—Epirubicin—ovarian cancer	0.000278	0.000847	CcSEcCtD
Valsartan—Cough—Doxorubicin—ovarian cancer	0.000277	0.000843	CcSEcCtD
Valsartan—Shock—Epirubicin—ovarian cancer	0.000275	0.000839	CcSEcCtD
Valsartan—Nervous system disorder—Epirubicin—ovarian cancer	0.000274	0.000836	CcSEcCtD
Valsartan—Dizziness—Docetaxel—ovarian cancer	0.000274	0.000836	CcSEcCtD
Valsartan—Thrombocytopenia—Epirubicin—ovarian cancer	0.000274	0.000835	CcSEcCtD
Valsartan—Skin disorder—Epirubicin—ovarian cancer	0.000272	0.000828	CcSEcCtD
Valsartan—Chest pain—Doxorubicin—ovarian cancer	0.00027	0.000823	CcSEcCtD
Valsartan—Myalgia—Doxorubicin—ovarian cancer	0.00027	0.000823	CcSEcCtD
Valsartan—Arthralgia—Doxorubicin—ovarian cancer	0.00027	0.000823	CcSEcCtD
Valsartan—Anxiety—Doxorubicin—ovarian cancer	0.000269	0.00082	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000268	0.000817	CcSEcCtD
Valsartan—Anorexia—Epirubicin—ovarian cancer	0.000267	0.000813	CcSEcCtD
Valsartan—Dry mouth—Doxorubicin—ovarian cancer	0.000264	0.000805	CcSEcCtD
Valsartan—Vomiting—Docetaxel—ovarian cancer	0.000264	0.000804	CcSEcCtD
Valsartan—Rash—Docetaxel—ovarian cancer	0.000262	0.000797	CcSEcCtD
Valsartan—Hypotension—Epirubicin—ovarian cancer	0.000261	0.000797	CcSEcCtD
Valsartan—Dermatitis—Docetaxel—ovarian cancer	0.000261	0.000796	CcSEcCtD
Valsartan—Headache—Docetaxel—ovarian cancer	0.00026	0.000792	CcSEcCtD
Valsartan—Oedema—Doxorubicin—ovarian cancer	0.000259	0.000789	CcSEcCtD
Valsartan—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000259	0.000789	CcSEcCtD
Valsartan—Infection—Doxorubicin—ovarian cancer	0.000257	0.000784	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000255	0.000777	CcSEcCtD
Valsartan—Shock—Doxorubicin—ovarian cancer	0.000255	0.000776	CcSEcCtD
Valsartan—Nervous system disorder—Doxorubicin—ovarian cancer	0.000254	0.000773	CcSEcCtD
Valsartan—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000254	0.000772	CcSEcCtD
Valsartan—Insomnia—Epirubicin—ovarian cancer	0.000253	0.000771	CcSEcCtD
Valsartan—Skin disorder—Doxorubicin—ovarian cancer	0.000251	0.000766	CcSEcCtD
Valsartan—Paraesthesia—Epirubicin—ovarian cancer	0.000251	0.000765	CcSEcCtD
Valsartan—Dyspnoea—Epirubicin—ovarian cancer	0.000249	0.00076	CcSEcCtD
Valsartan—Somnolence—Epirubicin—ovarian cancer	0.000249	0.000758	CcSEcCtD
Valsartan—Anorexia—Doxorubicin—ovarian cancer	0.000247	0.000752	CcSEcCtD
Valsartan—Nausea—Docetaxel—ovarian cancer	0.000246	0.000751	CcSEcCtD
Valsartan—Dyspepsia—Epirubicin—ovarian cancer	0.000246	0.00075	CcSEcCtD
Valsartan—Decreased appetite—Epirubicin—ovarian cancer	0.000243	0.000741	CcSEcCtD
Valsartan—Hypotension—Doxorubicin—ovarian cancer	0.000242	0.000737	CcSEcCtD
Valsartan—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000242	0.000736	CcSEcCtD
Valsartan—Fatigue—Epirubicin—ovarian cancer	0.000241	0.000735	CcSEcCtD
Valsartan—Constipation—Epirubicin—ovarian cancer	0.000239	0.000729	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000236	0.000719	CcSEcCtD
Valsartan—Insomnia—Doxorubicin—ovarian cancer	0.000234	0.000713	CcSEcCtD
Valsartan—Paraesthesia—Doxorubicin—ovarian cancer	0.000232	0.000708	CcSEcCtD
Valsartan—Dyspnoea—Doxorubicin—ovarian cancer	0.000231	0.000703	CcSEcCtD
Valsartan—Somnolence—Doxorubicin—ovarian cancer	0.00023	0.000701	CcSEcCtD
Valsartan—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000229	0.000697	CcSEcCtD
Valsartan—Dyspepsia—Doxorubicin—ovarian cancer	0.000228	0.000694	CcSEcCtD
Valsartan—Decreased appetite—Doxorubicin—ovarian cancer	0.000225	0.000686	CcSEcCtD
Valsartan—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000224	0.000681	CcSEcCtD
Valsartan—Fatigue—Doxorubicin—ovarian cancer	0.000223	0.00068	CcSEcCtD
Valsartan—Urticaria—Epirubicin—ovarian cancer	0.000222	0.000677	CcSEcCtD
Valsartan—Constipation—Doxorubicin—ovarian cancer	0.000221	0.000674	CcSEcCtD
Valsartan—Abdominal pain—Epirubicin—ovarian cancer	0.000221	0.000674	CcSEcCtD
Valsartan—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000212	0.000645	CcSEcCtD
Valsartan—Hypersensitivity—Epirubicin—ovarian cancer	0.000206	0.000628	CcSEcCtD
Valsartan—Urticaria—Doxorubicin—ovarian cancer	0.000206	0.000627	CcSEcCtD
Valsartan—Abdominal pain—Doxorubicin—ovarian cancer	0.000205	0.000623	CcSEcCtD
Valsartan—Asthenia—Epirubicin—ovarian cancer	0.000201	0.000612	CcSEcCtD
Valsartan—Pruritus—Epirubicin—ovarian cancer	0.000198	0.000603	CcSEcCtD
Valsartan—Diarrhoea—Epirubicin—ovarian cancer	0.000191	0.000583	CcSEcCtD
Valsartan—Hypersensitivity—Doxorubicin—ovarian cancer	0.000191	0.000581	CcSEcCtD
Valsartan—Asthenia—Doxorubicin—ovarian cancer	0.000186	0.000566	CcSEcCtD
Valsartan—Dizziness—Epirubicin—ovarian cancer	0.000185	0.000564	CcSEcCtD
Valsartan—Pruritus—Doxorubicin—ovarian cancer	0.000183	0.000558	CcSEcCtD
Valsartan—Vomiting—Epirubicin—ovarian cancer	0.000178	0.000542	CcSEcCtD
Valsartan—Diarrhoea—Doxorubicin—ovarian cancer	0.000177	0.00054	CcSEcCtD
Valsartan—Rash—Epirubicin—ovarian cancer	0.000176	0.000537	CcSEcCtD
Valsartan—Dermatitis—Epirubicin—ovarian cancer	0.000176	0.000537	CcSEcCtD
Valsartan—Headache—Epirubicin—ovarian cancer	0.000175	0.000534	CcSEcCtD
Valsartan—Dizziness—Doxorubicin—ovarian cancer	0.000171	0.000522	CcSEcCtD
Valsartan—Nausea—Epirubicin—ovarian cancer	0.000166	0.000506	CcSEcCtD
Valsartan—Vomiting—Doxorubicin—ovarian cancer	0.000165	0.000501	CcSEcCtD
Valsartan—Rash—Doxorubicin—ovarian cancer	0.000163	0.000497	CcSEcCtD
Valsartan—Dermatitis—Doxorubicin—ovarian cancer	0.000163	0.000497	CcSEcCtD
Valsartan—Headache—Doxorubicin—ovarian cancer	0.000162	0.000494	CcSEcCtD
Valsartan—Nausea—Doxorubicin—ovarian cancer	0.000154	0.000468	CcSEcCtD
